Yu. N. Belenkov

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Susan Dent, Susannah Stanway et al. · European Journal of Heart Failure · 2020 · 770 citations · Full text

Medicine, Cardiology, Oncology +16

Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

Jelena Čelutkienė, Radek Pudil, Teresa López‐Fernández et al. · European Journal of Heart Failure · 2020 · 365 citations · Full text

Medicine, Cardiology, Oncology +17

Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment

Yu. L. Begrambekova, Yu. A. Vasyuk, G. E. Gendlin et al. · Kardiologiia · 2018 · 360 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology

Radek Pudil, Christian Mueller, Jelena Čelutkienė et al. · European Journal of Heart Failure · 2020 · 344 citations · Full text

Medicine, Cardiology, Oncology +17

Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study

D. S. Polyakov, Yu. N. Belenkov, E. G. Artemjeva et al. · Kardiologiia · 2021 · 235 citations · Full text

Medicine, Cardiology, Internal Medicine +16